1997
DOI: 10.1016/s0002-9378(97)80085-3
|View full text |Cite
|
Sign up to set email alerts
|

Successful magnesium sulfate tocolysis: is “weaning” the drug necessary

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

1998
1998
2013
2013

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…GA was established based on an ultrasonographic examination before 20 wk in all instances. PTL was defined as the presence of regular uterine contractions and documented cervical effacement and/or dilatation in patients Ͻ37 wk GA (16). The diagnosis of PPROM was confirmed by visualization of AF pooling through the cervical os, nitrazine, ferning, or amniocentesis-dye positive tests.…”
Section: Methodsmentioning
confidence: 99%
“…GA was established based on an ultrasonographic examination before 20 wk in all instances. PTL was defined as the presence of regular uterine contractions and documented cervical effacement and/or dilatation in patients Ͻ37 wk GA (16). The diagnosis of PPROM was confirmed by visualization of AF pooling through the cervical os, nitrazine, ferning, or amniocentesis-dye positive tests.…”
Section: Methodsmentioning
confidence: 99%
“…Magnesium ions are involved as a cofactor in about 300 known enzymatic reactions in the body and in several important processes such as hormone receptor binding, gating of calcium channels, transmembrane ion¯ux, regulation of the adenylcyclase system, muscle contraction, neuronal activity, vaso-motor tone, cardiac excitability and neurotransmitter release [1]. As a pharmacological agent the use of magnesium sulphate is established for the treatment of supraventricular [2] and ventricular dysrhythmias [3], especially torsades de pointes [4], asthma [5], for tocolysis [6] and eclampsia [7,8]. The role of magnesium in the treatment of acute myocardial infarction remains unclear [1,9].…”
Section: Introductionmentioning
confidence: 99%
“…Magnesium ions are involved as a cofactor in about 300 known enzymatic reactions in the body and in several important processes such as hormone receptor binding, gating of calcium channels, transmembrane ion flux, regulation of the adenylcyclase system, muscle contraction, neuronal activity, vasomotor tone, cardiac excitability and neurotransmitter release [1]. As a pharmacological agent the use of magnesium sulphate is established for the treatment of supraventricular [2] and ventricular dysrhythmias [3], especially torsades de pointes [4], asthma [5], for tocolysis [6] and eclampsia [7,8]. The role of magnesium in the treatment of acute myocardial infarction remains unclear [1,9].…”
Section: Introductionmentioning
confidence: 99%